NUTRACEUTICALS WORLD.COM REPORTS
MEMORIAL SLOAN-KETTERING CANCER CENTER
STARTING PHASE II CLINICAL TRIAL FOR MDS

Yukiguni Maitake Extract being used by
Memorial Sloan-Kettering Cancer Center
For MDS Phase II Clinical trial

Please click for the full Maitake Mushroom Research
Phase II Clinical Trial Article
May 17, 2010

The material used in this trial is commercially available in the U.S. through our affiliate the Tradeworks Group Inc.
For more details, visit www.maitakegold.com

Cancer Research Center
relies on patented Maitake Mushroom Extract
for Phase II Clinical Trial

January 27, 2010

World’s largest maitake cultivator,
Yukiguni Maitake Company, Ltd. celebrates
continued study of its unique product